Home Contact Us
  • For more information about
    Tripos products and services
    please contact us:
    800-323-2960

  • Tel: +1-314-647-1099
  • Fax: +1-314-647-9241
Home > News & Events > Tripos Tribune

Tripos Tribune


Welcome to the June issue of the Tripos Tribune! In this edition, you’ll learn about a new product releases and get the opportunity to register for upcoming events in the Tripos Summer Webinar Series.  In our Faces feature, you’ll meet Bernd Wendt, Senior Scientist at Tripos in Germany, and get introduced to William Cobert, newly appointed Vice President of Sales in Europe.   Enjoy!

In this edition

Tripos in the News
SYBYL News
KNIME
Events
Tripos Science Summit
Faces of Science
Scientific Publications
Survey Winners
Register your Interests


Tripos in the News 

Dick Cramer, Senior Vice President, Science & Chief Scientific Officer at Tripos, was interviewed recently for an article focusing on QSAR for Drug Discovery and Development which was published in the May edition of the magazine:   

Structure Predicts Function
by James Netterwald, PhD, MT (ASCP), Contributing Editor

A link to the full article can be found here:  http://www.dddmag.com/Article-QSAR-Methods-050509.aspx


SYBYL News 

SYBYL imageThe SYBYL 8.1.1 update release is now available for the Mac and Linux platforms.

With the SYBYL 8.1.1 update release, Linux users will receive new features including a ligand preparation workflow.   This is a tool that will provide simplified paths for preparing molecular structures in the appropriate chemical representation needed for a variety of applications; such as Docking and Topomeric studies.

Of special interest to Mac users are fixes to MMFF94 atom typing and to very rare behavior regarding ordering of files in CScore.  Also, a script is provided to fix the Orchestrar database used in CODA.  The ligand preparation workflow will be available for Mac users in a subsequent release.

Customers with current support contracts can download SYBYL 8.1.1 from the download center on the Tripos web site*.

*Log on required.  Installation of the SYBYL 8.1.1 update release requires that the SYBYL 8.1 media release be installed as a prerequisite.  Also, users must have ConcordStandalone, Confort, StereoPlex, ProtoPlex, ClogP/CMR (Biobyte), Selector (CmpdSel) to utilize the new ligand preparation workflow.


Knime
Open Beta Program: Tripos Chemistry Extensions for KNIME v2.0

Tripos has released a beta version of a new release of the Tripos Chemistry
Extensions for KNIME (TCE for KNIME) version 2.0.

The TCE for KNIME 2.0 is available for a public, no-charge beta test until August 10, 2009.

KNIME is an open-source data exploration platform that enables users to visually create data flows, often referred to as pipelines. KNIME enables discovery scientists to rapidly orchestrate technologies from multiple vendors to process and analyze data-intensive workflows, and later investigate the results through interactive views on data and models.

Tripos’ Chemistry Extensions for KNIME provide KNIME users with tools to interpret
and process chemical structures and perform cheminformatics tasks such as 2D and
3D database searching.

New Capabilities include:

  • 2D substructure and similarity searching
  • 3D searching
  • Ability to read UNITY databases
  • Ability to build HQSAR models and perform predictions with HQSAR
  • models

Download the TCE for KNIME beta today!* 
*registration required


Events  

Complimentary Summer Webinar Series   

Tripos has kicked off a new summer series of live webinars on topics relevant to drug and molecular discovery.  We invite you to register for upcoming events:

  • Using Benchware Discovery 360 to Access the Web of Pharmaceutical Research Data and Enhance Science and Productivity

    In this webinar we will demonstrate how Benchware Discovery 360 (D360) allows scientists to quickly and easily obtain the data they need, understand that data through integrated scientific analysis tools, and share findings with their project teams. D360 supports all scientific informatics tasks from easily creating project SAR tables, to understanding what compounds are in stock and what reagents are available and comparing projects and finding specific assays.

  • Multi-Parameter Structure Based Drug Design

    A multi-criteria structure based scoring function for use in de novo design will be described and an example demonstrating its utility for drug discovery will be given. We use a popular docking tool, Surflex-Dock, to pose and score invented structures inside the active site. Using Surflex-Dock’s ability to guide the docking process with single or multiple placed fragments, Muse can be applied in fragment based drug discovery by inventing scaffolds interconnecting the placed fragments. In addition, a number of simple molecular properties (e.g. LogP, Lipinski properties, etc.) are used as score components to focus the design on medicinally relevant chemistries. This demonstrates the power of Muse to be used with both structure- and ligand-based scoring to generate ideas that meet multiple design criteria.

  • Homology Modeling: Using Protein Information to Design New Targets

    Knowledge of protein structure plays an important role in the drug discovery process. The discipline of structure-based drug design uses the protein structure to guide drug development. Despite the progress in protein crystallization the gap between the number of known sequences and experimentally determined structures remains significant. So efficient and precise methods to speed up the development of protein models can increase the number of successful drug design projects in industry. Homology Modeling is used to build three-dimensional models for an unknown protein target based upon single or multiple templates with known structure.

  • R-Group Virtual Screening: A New CADD Capability for Lead Optimization

    Dr. Cramer will discuss the strategic use and value of utilizing R-Group Virtual Screening to jump start or rescue start lead optimization projects. The webinar will illustrate how Tripos' R-Group Virtual Screening workflow provides unprecedented capability to discover novel, yet shape similar, R-groups promising to confer superior potency within large structure collections, enabling scientists to find novel R-groups predicted to have high potency, optimize multiple parameters, and get hundreds of new, highly promising R-group ideas. The presentation will include a software demonstration illustrating the ease with which this workflow can be implemented in medicinal chemistry or CADD groups.

Explore the Online Event Archive and listen to recordings of webcasts you missed, including the inaugural event in the Summer Webinar Series:

Surflex-Dock: A Unique, Effective, and Customizable Docking Solution
Presenter: Ajay N. Jain, Ph.D., Professor, Cancer Research Institute & Department of Lab Medicine, University of California San Francisco


Tripos Science Summit- Analyze, Optimize, Socialize
September 28-29· Tripos Munich Office
September 30 and October 1· Union League of Philadelphia
 

Mark your calendar and make plans to attend the European Tripos Science Summit!  Offered at no cost to delegates, you'll interact with your peers in the Tripos User Community, share innovative research strategies and discuss the complexities of today’s drug discovery environment at the Tripos Science Summit.  The European meeting will feature a visit to Oktoberfest so sign up now to reserve your seat!  


Meet Dr. Bernd Wendt 
Senior Scientist

Dr. Bernd Wendt serves as Head of Computational Chemistry at Elara Pharmaceuticals GmbH, Heidelberg, Germany. He is also working as Senior Scientist for Tripos. He has more than 10 years of experience in the life science industry, specializing in molecular design and data mining techniques. Prior to working for Elara he was working for Tripos’ Chemistry Research Centre in the UK, where he has been senior scientist, project and strategic alliance manager. He was involved in many collaborative research projects, working with biotech and Pharma companies in lead discovery and optimization projects. Bernd earned his Diploma and Ph.D.  in Chemistry/Biochemistry at the Philipps University Marburg.

Bernd is married and has 3 sons with whom he enjoys racing in biking and hiking activities.


Scientific Publications  

New articles written by Tripos authors or featuring Tripos technologies have just been published in peer-reviewed journals:

  • Discovery of Novel Myc#Max Heterodimer Disruptors with a Three-Dimensional Pharmacophore Model
    Gabriela Mustata, Ariele Viacava Follis, Dalia I. Hammoudeh, Steven J. Metallo, Huabo Wang, Edward V. Prochownik, John S. Lazo, Ivet Bahar
    Journal of Medicinal Chemistry 2009 [Epub ahead of print]

    A three-dimensional pharmacophore model was generated utilizing a set of known inhibitors of c-Myc-Max heterodimer formation. The model successfully identified a set of structurally diverse compounds with potential inhibitory activity against c-Myc. Nine compounds were tested in vitro, and four displayed affinities in the micromolar range and growth inhibitory activity against c-Myc-overexpressing cells. These studies demonstrate the applicability of pharmacophore modeling to the identification of novel and potentially more puissant inhibitors of the c-Myc oncoprotein.
  • Homology modeling of human α1β2γ2 and house fly β3 GABA receptor channels and Surflex-docking of fipronil
    Cheng J, Ju XL, Chen XY, Liu GY
    J Mol Model. 2009 [Epub ahead of print]

    To further explore the mechanism of selective binding of the representative gamma-aminobutyric acid receptors (GABARs) noncompetitive antagonist (NCA) fipronil to insect over mammalian GABARs, three-dimensional models of human alpha1beta2gamma2 and house fly beta3 GABAR were generated by homology modeling, using the cryo-electron microscopy structure of the nicotinic acetylcholine receptor (nAChR) of Torpedo marmorata as a template. Fipronil was docked into the putative binding site of the human alpha1beta2gamma2 and house fly beta3 receptors by Surflex-docking, and the calculated docking energies are in agreement with experimental results. The GABA receptor antagonist fipronil exhibited higher potency with house fly beta3 GABAR than with human alpha1beta2gamma2 GABAR. Furthermore, analyses of Surflex-docking suggest that the H-bond interaction of fipronil with Ala2 and Thr6 in the second transmembrane segment (TM2) of these GABARs plays a relatively important role in ligand selective binding. The different subunit assemblies of human alpha1beta2gamma2 and house fly beta3 GABARs may result in differential selectivity for fipronil.
  • Octahydrophenanthrene-2,7-diol Analogues as Dissociated Glucocorticoid Receptor Agonists: Discovery and Lead Exploration
    Robinson RP, Buckbinder L, Haugeto AI, McNiff PA, Millham ML, Reese MR, Schaefer JF, Abramov YA, Bordner J, Chantigny YA, Kleinman EF, Laird ER, Morgan BP, Murray JC, Salter ED, Wessel MD, Yocum SA.
    J Med Chem. 2009 52(6):1731-43

    As exemplified by the lead compound 2, octahydrophenanthrene-2,7-diol analogues exhibit the profile of a pathway-selective or "dissociated" agonist of the glucocorticoid receptor (GR), retaining the potent activity that glucocorticoids have for transrepression (as measured by inhibition of IL-1 induced MMP-13 expression) but showing an attenuated capacity for transactivation (as measured in an MMTV luciferase reporter assay). With the guidance of a homology model of the GR ligand binding domain, structural modifications to 2 were carried out that were successful in replacing the allyl and propynyl side chains with groups likely to be more chemically stable and less likely to produce toxic metabolites. Key to success was the introduction of an additional hydroxyl group onto the tricyclic carbon framework of the series.

Survey Winners

 CADD Survey & CADD Follow up Survey Winners  In early April, Tripos sent out a CADD survey to which the response was overwhelming.  Thanks to everyone who participated. As promised, all respondents who provided contact information were entered into a drawing to win an Apple iPod®.  Congratulations to our winner, Dong Sun Park.  Tripos also sent out two CADD Follow up surveys in the middle of May in which participants were entered in a drawing to win an Apple iPod®.  Congratulations to our winners, Anil Mehta and Mark Hellberg.

Tripos will use the CADD surveys in a number of ways: 
     • Understand the areas in which we are successful 
     • Discover new approaches to enhancing our products and services

Medicinal Chemistry Software Toolkit Survey Winner  Thanks to all who participated in the  Medicinal Chemistry Software Toolkit survey that Tripos sent out early May.  Congratulations to Guy Vigers, our winner of an Apple iPod® Touch.


Register Your Interests image

    •   • Would you like to receive email notification of software updates
    •     and releases? 
    •   • Are you interested in having Tripos news releases sent to your
    •     inbox?  
    •   • Want to have input in what is featured in the Tripos Tribune?

Sign up for the Tripos newsletter and register your interests - we'll take it from there and send relevant content based on your selections.